EUVIMEDEUVIMED entdecken
Crossref

Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease

Han-Kyeol Kim iD, Taewon Kim, Min Seok Baek, Eung Yeop Kim iD, Young Hee Sung, Jae Hoon Lee, Young Hoon Ryu, Sung Jun Ahn, Han Soo Yoo iD, Chul Hyoung Lyoo iD

European Journal of Neurology · 2023-06 · 30 (6) · 1639-1647

DOI: 10.1111/ene.15781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 26.03.2023. Verfasst von Han-Kyeol Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Yonsei University College of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nigrosome 1 (NG1), a small cluster of dopaminergic cells in the substantia nigra and visible in the susceptibility map‐weighted magnetic resonance image (SMwI), is severely affected in Parkinson's disease (PD). However, the degree of nigrostriatal degeneration according to the visibility of NG1 has not yet been well elucidated.

Methods

We consecutively recruited 138 PD and 78 non‐neurodegenerative disease (non‐ND) patients, who underwent both 18 F‐FP‐CIT positron emission tomography (PET) and SMwI. Three neurologists and one radiologist evaluated the visibility of NG1 in SMwI. The participants were thereby grouped into visible, intermediate, and non‐visible groups. Nigrostriatal dopaminergic input was calculated using the specific binding ratio (SBR) of the 18 F‐FP‐CIT PET. We determined the threshold of regional SBR for discriminating NG1 visibility and the probability for NG1 visibility according to regional SBR.

Results

Visual rating of NG1 showed excellent interobserver agreements as well as high sensitivity and specificity to differentiate the PD group from the non‐ND group. NG1 was visible in seven patients (5.1%) in the PD group, who had relatively short disease duration or less severe loss of striatal dopamine. The threshold of putaminal SBR reduction on the more affected side for the disappearance of NG1 was 45.5%, and the probability for NG1 visibility dropped to 50% after the reduction of putaminal SBR to 41% from the normal mean.

Conclusions

Almost half loss of nigrostriatal dopaminergic input is required to dissipate the hyperintensity of NG1 on SMwI, suggesting its utility in diagnosing PD only after the onset of the motor symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHumansDopamineTropanesPositron-Emission TomographyCorpus StriatumTomography, Emission-Computed, Single-PhotonSubstantia NigraDopamine Plasma Membrane Transport Proteins

Stichwörter der Autor:innen

Parkinson's diseaseSMwIdopamine transporternigrosome 1nigrostriatal degenerationvisual assessment

Substanzen

2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropaneDopamineTropanesDopamine Plasma Membrane Transport Proteins

Autor:innen und Institutionen

  • Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Neurology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea.
  • Department of Radiology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, South Korea.
  • Department of Neurology, Gachon University Gil Medical Center, Incheon, South Korea.
  • Department of Radiology, Gangnam Severance Hospital, College of Medicine, Yonsei University, Seoul, South Korea.
  • Department of Nuclear Medicine, Gangnam Severance Hospital, College of Medicine, Yonsei University, Seoul, South Korea.

ORCID-Profile: Han-Kyeol Kim, Eung Yeop Kim, Han Soo Yoo, Chul Hyoung Lyoo

Förderung

  • Yonsei University College of Medicine

Zitieren

APA

Kim, H. K., Kim, T., Baek, M. S., Kim, E. Y., Sung, Y. H., Lee, J. H., Ryu, Y. H., Ahn, S. J., Yoo, H. S., & Lyoo, C. H. (2023). Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease. European Journal of Neurology, 30(6), 1639-1647. https://doi.org/10.1111/ene.15781

Vancouver

Kim HK, Kim T, Baek MS, Kim EY, Sung YH, Lee JH, et al. Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease. European Journal of Neurology. 2023;30(6):1639-1647. doi:10.1111/ene.15781

BibTeX
@article{Kim2023,
  author = {Kim, Han-Kyeol and Kim, Taewon and Baek, Min Seok and Kim, Eung Yeop and Sung, Young Hee and Lee, Jae Hoon and Ryu, Young Hoon and Ahn, Sung Jun and Yoo, Han Soo and Lyoo, Chul Hyoung},
  title = {Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease},
  journal = {European Journal of Neurology},
  year = {2023},
  volume = {30},
  number = {6},
  pages = {1639--1647},
  doi = {10.1111/ene.15781}
}
Kostenlos starten →